GA

Grayson Allen

CFO/COO & Co-Founder

Professional Background



D. Grayson Allen currently serves as the Chief Operations Officer (COO) and Chief Financial Officer (CFO) at RevBio, Inc., a company specializing in bioadhesive technology for bone repair. Grayson is also a Co-Founder of the company. He has over 18 years of extensive experience in financial management, particularly within start-ups and growth companies. Grayson oversees financial planning, reporting functions, and is significantly involved in strategic and tactical decisions at RevBio.

Previous Experience



  • Chief Financial Officer at AeroSat Corporation

  • Chief Financial Officer at North American Industries

  • Interim CFO for multiple organizations via Tatum, a management consulting firm

  • Principal at Citizens Capital Markets


Grayson has highlighted roles that included:
  • Providing strategic financial leadership across various sectors including diagnostics, medical devices, and healthcare companies.

  • Creating and managing finance teams, implementing infrastructure and processes necessary for rapid growth and expansion.

  • Raising over $120 million in cumulative investment capital.


Education



  • Bachelor of Arts (BA) from Dartmouth College

  • Master of Business Administration (MBA) from MIT Sloan School of Management


Notable Achievements at RevBio



  • FDA Approval: Grayson announced that RevBio received FDA approval to start its first-in-human clinical trial for the company's cranial flap fixation product and a more biologically active formulation.

  • Strategic Investments: RevBio received a strategic investment from Pacific Dental Services, which Grayson publicly acknowledged.

  • NIH Grant: Recently, RevBio was awarded a $3.4 million NIH grant for further research and development, showcasing Grayson’s leadership in securing external funding.


Relevant Skills and Expertise



Grayson Allen brings a unique blend of financial acumen, venture capital experience, and operational management to RevBio. His background spans across multiple companies where he has implemented financial systems conducive to significant growth. His strategic mindset and ability to secure substantial investment capital are key assets for RevBio's expansion and innovation initiatives.

Contact Details



  • Location: Boston, MA



Company Overview: RevBio, Inc.



RevBio, Inc. is at the forefront of developing TETRANITE®, a regenerative bone adhesive with a broad application spectrum in both human and animal health. The company is headquartered in Lowell, Massachusetts, and has a strong foundation in bio-inspiration, drawing technology insights from the natural world, specifically the Sandcastle Worm.

Recent Highlights



  • FDA Approvals: Multiple approvals to conduct clinical trials on new biomimetic bone adhesive formulations.

  • Investment and Grants: Strategic investment from prominent organizations and substantial NIH grants.

  • Innovative Technology: The patented bioadhesive technology developed by RevBio has won numerous grants and received multiple patents, demonstrating significant potential in transforming bone repair treatments.


By understanding Grayson Allen's key role and contributions to RevBio, your approach can be tailored to align with their strategic interests and ongoing projects in groundbreaking medical technologies.